5AM Venture Management’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-251,994
Closed -$4.52M 29
2024
Q2
$4.52M Hold
251,994
1.01% 23
2024
Q1
$4.29M Sell
251,994
-2
-0% -$28 0.96% 25
2023
Q4
$2.76M Hold
251,996
0.73% 23
2023
Q3
$5.31M Hold
251,996
1.53% 21
2023
Q2
$4.01M Hold
251,996
1% 21
2023
Q1
$4.67M Hold
251,996
1.19% 20
2022
Q4
$5.72M Hold
251,996
1.54% 19
2022
Q3
$7.3M Hold
251,996
1.4% 15
2022
Q2
$8.94M Hold
251,996
2.21% 15
2022
Q1
$13.8M Hold
251,996
3.01% 13
2021
Q4
$16.5M Hold
251,996
3.1% 11
2021
Q3
$35.7M Hold
251,996
7.25% 4
2021
Q2
$33M Hold
251,996
8.3% 4
2021
Q1
$42.7M Hold
251,996
7.69% 3
2020
Q4
$51.2M Sell
251,996
-55,555
-18% -$10.7M 17.25% 2
2020
Q3
$59.2M Hold
307,551
15.58% 2
2020
Q2
$84.1M Hold
307,551
18.42% 3
2020
Q1
$86M Hold
307,551
26.64% 2
2019
Q4
$115M Buy
+307,551
New +$88.1M 24.66% 2

Other funds holding QTTB

5AM Venture Management's QTTB Position: Q3 2024 in Review

5AM Venture Management sold out of Q32 Bio (QTTB) in Q3 2024, closing a stake of 251,994 shares — an estimated $4.52M sold.

5AM Venture Management first reported a position in QTTB in Q4 2019 and held it in 19 quarters. The position peaked at $115M in Q4 2019. 73 funds tracked by Wall St. Rank hold QTTB as of Q3 2024.

  • 5AM Venture Management reported no remaining Q32 Bio position as of Q3 2024 after selling out during the quarter.
  • 5AM Venture Management sold 251,994 Q32 Bio shares in Q3 2024, an estimated $4.52M.
  • 5AM Venture Management first reported a position in Q32 Bio in Q4 2019 and held it in 19 quarters.
  • 5AM Venture Management's Q32 Bio position peaked at $115M in Q4 2019.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2024.

Based on 5AM Venture Management's 13F filing for Q3 2024, filed 14 Nov 2024.